2022年9月13日

EDGC(某人Diagnomics基因組中心)新兵山姆·馬丁海外業務發展副總裁……“加速進入海外市場”EDGC Invitae和櫥櫃遺傳學專家,美國基因組分析公司EDGC州,“我們將擴大海外基因組分析市場,進軍全球液體活檢技術市場招聘基因組領域的全球人才”在一個非營利研究組織(ShareGenome) EDGC首席執行官李Min-Seob聖地亞哥,9月13日,2022年EDGC從(某人Diagnomics基因組中心),公司專門從事基因組分析和精密醫學,在13日宣布,山姆·馬丁已經聘請海外業務發展副總裁。海外業務發展的副總裁薩姆·馬丁,EDGC(某人Diagnomics基因組中心)通過招募山姆馬丁,他有著豐富的經驗和網絡在基因組海外市場,EDGC將全麵進入海外市場,鞏固全球生物公司的地位。山姆·馬丁是一個美國執照基因顧問擁有多個人類遺傳學碩士學位/遺傳谘詢和軟件工程師和設計來自美國。他最近為Invitae和櫥櫃遺傳學工作,兩家美國頂級遺傳學公司專門從事個人基因組醫學。他也有臨床經驗遺傳谘詢,工作8年在貝斯以色列醫院在紐約市。山姆·馬丁加入與首席執行官李Min-Seob EDGC因為他的關係。山姆·馬丁於1978年出生在韓國,被一對美國夫婦收養。正因為如此,他與李Min-Seob ShareGenome,一個非營利性研究機構,找到被收養者的韓國家庭通過個體的遺傳分析。山姆·馬丁說:“我很自豪有一個生物公司優良的基因技術和高全球商業競爭力EDGC在韓國,,我也又回到我出生的地方和工作的領導人在基因組醫學。” He also stated, "Based on the excellent technology of EDGC, which is recognized in the global market, I will further expand the overseas business and focus all my competencies for the success of K-Bio." EDGC is a public genomics company listed on the KOSDAQ in 2018. The company is receiving great attention in the global market for its liquid biopsy, a core technology for cancer and prenatal diagnosis. The 'ONCOCATCH' for early cancer screening and precision diagnosis, EDGC's representative liquid biopsy technology, is a third-generation innovative technology. It is also receiving great attention in both academia and industry, as GenomeWeb recently evaluated that it would open a new chapter for early cancer diagnosis, its technology and business feasibility are being formally recognized. Sam Martin Vice President Profile University of Minnesota, Minneapolis, MN - B.S. Genetic and Cell Development, Minor Psychology Sarah Lawrence College, Bronxville, NY - M.S. Human Genetics, Genetic Counseling Pace University, New York, NY - M.S. Software Engineer and Design Genetic Counselor, Beth Israel Medical Center - 2006-2014 Business Development Manager, Signifikance, Inc - 2014-2015 Genetic Specialist (MSL), Ambry Genetics - 2015-2017 Clinical Science Liaison (MSL), Invitae - 2017- 2019 Regional Account Manager, Asia, Invitae - 2019- 2022